BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 31, 2002
View Archived Issues
Human Genome Sciences compounds advance into the clinic in second quarter
Read More
Apomine enters proof-of-principle trial in osteoporosis
Read More
Enrollment complete in tecadenoson phase III trial
Read More
Third-generation beta1/alpha-adrenoceptor blocker with hypotensive and bradycardic effects
Read More
Bifunctional fusion protein targeting breast cancer cells active in murine model
Read More
Safety and efficacy demonstrated for phVEGF2 in dose-escalating phase I/II trial
Read More
Liposomal TOP-53 may be associated with improved tolerance
Read More
Manufacturing approval obtained for Onoact
Read More
AstraZeneca presents new ERbeta ligands for AD and other disorders
Read More
Sepracor scientists identify new opioid and other GPCR ligands
Read More
Antidiabetic glucokinase activators identified at Roche
Read More
ZymoGenetics signs IL-13 receptor license agreement with Wyeth
Read More
Novel PPARalpha receptor agonists in the GSK pipeline
Read More
Roche scientists describe novel COX-2 inhibitors and their use
Read More
Major European launch for Otsuka antithrombotic agent
Read More
Carboxylic acid-based PPAR agonists in development at Kyorin
Read More
HDAC-inhibitory hydroxamates recently described in Roche patent
Read More
Genset licenses rights for Chlamydia genomic sequences to Ricerca
Read More
DNA minor groove-binding antitumor agent with potential in refractory tumors
Read More
Mitsubishi Chemical invests in IC-Vec for nonviral cancer gene therapy
Read More
GlaxoSmithKline to collaborate with elbion on PDE4 inhibitor development
Read More
Vernalis and Roche update obesity collaboration progress
Read More
Xyotax enters phase III evaluation in ovarian cancer
Read More
Roche licenses Alzheimer's compounds from Memory
Read More
Exhale licenses hyaluronic acid for prevention of group A streptococcal pharyngitis
Read More
Arixtra launched in Germany for preventing VTEs
Read More
Potential new treatment for cystic fibrosis designated an orphan drug
Read More